LLY

1,051.04

-0.27%↓

JNJ

205.32

+1.07%↑

ABBV

234.12

+2.17%↑

UNH

318.01

+1.93%↑

AZN

90.29

+0.61%↑

LLY

1,051.04

-0.27%↓

JNJ

205.32

+1.07%↑

ABBV

234.12

+2.17%↑

UNH

318.01

+1.93%↑

AZN

90.29

+0.61%↑

LLY

1,051.04

-0.27%↓

JNJ

205.32

+1.07%↑

ABBV

234.12

+2.17%↑

UNH

318.01

+1.93%↑

AZN

90.29

+0.61%↑

LLY

1,051.04

-0.27%↓

JNJ

205.32

+1.07%↑

ABBV

234.12

+2.17%↑

UNH

318.01

+1.93%↑

AZN

90.29

+0.61%↑

LLY

1,051.04

-0.27%↓

JNJ

205.32

+1.07%↑

ABBV

234.12

+2.17%↑

UNH

318.01

+1.93%↑

AZN

90.29

+0.61%↑

Search

ICU Medical Inc

Open

BrancheGesundheitswesen

138.51 4.74

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

131.56

Max

138.84

Schlüsselkennzahlen

By Trading Economics

Einkommen

-39M

-3.4M

Verkäufe

-12M

537M

Gewinnspanne

-0.632

Angestellte

15,000

EBITDA

-40M

67M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+28.04% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

288M

3.3B

Vorheriger Eröffnungskurs

133.77

Vorheriger Schlusskurs

138.51

Nachrichtenstimmung

By Acuity

50%

50%

182 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

ICU Medical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

20. Nov. 2025, 23:07 UTC

Market Talk

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

20. Nov. 2025, 22:22 UTC

Market Talk

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

20. Nov. 2025, 22:08 UTC

Market Talk

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

20. Nov. 2025, 21:57 UTC

Ergebnisse

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

20. Nov. 2025, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

20. Nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20. Nov. 2025, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

20. Nov. 2025, 21:50 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

20. Nov. 2025, 21:31 UTC

Ergebnisse

Nvidia's Strong Results Show AI Fears Are Premature -- Update

20. Nov. 2025, 21:23 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

20. Nov. 2025, 21:07 UTC

Ergebnisse

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20. Nov. 2025, 21:06 UTC

Ergebnisse

Webull 3Q Rev $156.9M >BULL

20. Nov. 2025, 21:06 UTC

Ergebnisse

Webull 3Q EPS 7c >BULL

20. Nov. 2025, 21:05 UTC

Ergebnisse

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

20. Nov. 2025, 21:04 UTC

Ergebnisse

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

20. Nov. 2025, 21:04 UTC

Ergebnisse

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

20. Nov. 2025, 21:04 UTC

Ergebnisse

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Backs FY26 Rev $21B-$21.19B >INTU

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit 1Q Consumer Rev $894M

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Backs FY26 Guidance

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

20. Nov. 2025, 21:00 UTC

Ergebnisse

Intuit 1Q Global Business Solutions Rev $3B

Peer-Vergleich

Kursveränderung

ICU Medical Inc Prognose

Kursziel

By TipRanks

28.04% Vorteil

12-Monats-Prognose

Durchschnitt 172 USD  28.04%

Hoch 172 USD

Tief 172 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ICU Medical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

2

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

137.16 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Strong Bearish Evidence

Stimmung

By Acuity

182 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat